Simplify diagnosis of invasive aspergillosis

The new IMMY sõna Aspergillus Galactomannan Lateral Flow Assay is now available in the UK exclusively from Alpha Laboratories.

The immunochromatographic test system for the qualitative detection of Aspergillus Galactomannan in serum and BAL samples, has been developed to provide a simplified test procedure and rapid turnaround time for the diagnosis of invasive aspergillosis. 

Aspergillus GM LFA provides high sensitivity and specificity, while the simple format and rapid 30 minute test time eliminates the need for batch testing. When used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples and radiographic evidence, the Aspergillus GM LFA aids the diagnosis of aspergillosis. Improved diagnostics could lead to better treatment outcomes and higher survival rates. 

Over 30 million people are at risk of invasive aspergillosis each year and over 300,000 patients develop it annually. The disease is common in high risk patients with: haematological malignancies, chemotherapyinduced neutropenia, allogeneic HSCT (stem cell transplant) and who have undergone solid organ transplant (primarily lung).

 

 

More about Alpha Laboratories

 

Other news

Upcoming Events

BSA Annual Conference 2019: Translating Research into Practice

Molineux Stadium, Wolverhampton
Wednesday 5th June

Sepsis + Conference 2019

National Conference Centre Birmingham
11th June

Knowlex: Patient Safety 2019

NCC Birmingham
11th June 2019

BSG Annual Meeting 2019

Glasgow
Monday 17th June to Thursday 20th June 2019

AfPP Residential 2019

York University
8th to the 11th August

Latest Issue

Clinical Services Journal

Clinical Services Journal

May 2019

Improving safety for both staff and patients

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Apr 2019

Putting patients and hospitals first

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.